Provision of cancer care during the COVID-19 pandemic

Health-care services are rapidly transforming their organization and workforce in response to the coronavirus disease 2019 (COVID-19) pandemic. These changes, and a desire to mitigate infection risk, are having profound effects on other vital aspects of care, including the care of patients with canc...

Descripción completa

Detalles Bibliográficos
Autores principales: Spicer, James, Chamberlain, Charlotte, Papa, Sophie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Comment
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7156894/
https://www.ncbi.nlm.nih.gov/pubmed/32296166
http://dx.doi.org/10.1038/s41571-020-0370-6
_version_ 1783522308373086208
author Spicer, James
Chamberlain, Charlotte
Papa, Sophie
author_facet Spicer, James
Chamberlain, Charlotte
Papa, Sophie
author_sort Spicer, James
collection PubMed
description Health-care services are rapidly transforming their organization and workforce in response to the coronavirus disease 2019 (COVID-19) pandemic. These changes, and a desire to mitigate infection risk, are having profound effects on other vital aspects of care, including the care of patients with cancer. Difficult decisions are being made regarding the prioritization of both active treatments and palliative care, despite limited evidence that cancer is an independent risk factor for infection and mortality.
format Online
Article
Text
id pubmed-7156894
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-71568942020-04-15 Provision of cancer care during the COVID-19 pandemic Spicer, James Chamberlain, Charlotte Papa, Sophie Nat Rev Clin Oncol Comment Health-care services are rapidly transforming their organization and workforce in response to the coronavirus disease 2019 (COVID-19) pandemic. These changes, and a desire to mitigate infection risk, are having profound effects on other vital aspects of care, including the care of patients with cancer. Difficult decisions are being made regarding the prioritization of both active treatments and palliative care, despite limited evidence that cancer is an independent risk factor for infection and mortality. Nature Publishing Group UK 2020-04-15 2020 /pmc/articles/PMC7156894/ /pubmed/32296166 http://dx.doi.org/10.1038/s41571-020-0370-6 Text en © Springer Nature Limited 2020 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Comment
Spicer, James
Chamberlain, Charlotte
Papa, Sophie
Provision of cancer care during the COVID-19 pandemic
title Provision of cancer care during the COVID-19 pandemic
title_full Provision of cancer care during the COVID-19 pandemic
title_fullStr Provision of cancer care during the COVID-19 pandemic
title_full_unstemmed Provision of cancer care during the COVID-19 pandemic
title_short Provision of cancer care during the COVID-19 pandemic
title_sort provision of cancer care during the covid-19 pandemic
topic Comment
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7156894/
https://www.ncbi.nlm.nih.gov/pubmed/32296166
http://dx.doi.org/10.1038/s41571-020-0370-6
work_keys_str_mv AT spicerjames provisionofcancercareduringthecovid19pandemic
AT chamberlaincharlotte provisionofcancercareduringthecovid19pandemic
AT papasophie provisionofcancercareduringthecovid19pandemic

Ejemplares similares